Skip to main content
. Author manuscript; available in PMC: 2010 Dec 21.
Published in final edited form as: J Cardiovasc Transl Res. 2010 May 27;3(4):330–343. doi: 10.1007/s12265-010-9192-8

Fig. 1.

Fig. 1

GPCRs signaling in hypertrophy, survival, and failure. Dashed lines indicate pathways that the authors do not consider to be predominant. Abbreviations: NE norepinephrine, PE phenylephrine, ET-1 endothelin-1, S1P sphingosine 1-phosphate, LPA lysophosphatidic acid, I/R ischemia/reperfusion, InsP3 inositol-1,4,5-triphosphate, DAG diacylglycerol, PLC phospholipase C, RhoGEF rho guanine nucleotide exchange factor, PKC, protein kinase C, CaMK, calcium–calmodulin-dependent kinase, CaN, calcineurin, ROCK rho-associated coiled-coil containing protein kinase, FAK focal adhesion kinase, PLD phospholipase D